Hans A.R. Bluyssen

3.6k total citations
72 papers, 2.8k citations indexed

About

Hans A.R. Bluyssen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Hans A.R. Bluyssen has authored 72 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 36 papers in Immunology and 34 papers in Molecular Biology. Recurrent topics in Hans A.R. Bluyssen's work include Cytokine Signaling Pathways and Interactions (35 papers), interferon and immune responses (21 papers) and Atherosclerosis and Cardiovascular Diseases (12 papers). Hans A.R. Bluyssen is often cited by papers focused on Cytokine Signaling Pathways and Interactions (35 papers), interferon and immune responses (21 papers) and Atherosclerosis and Cardiovascular Diseases (12 papers). Hans A.R. Bluyssen collaborates with scholars based in Poland, Netherlands and United States. Hans A.R. Bluyssen's co-authors include Joanna Wesoły, David T. Levy, Katarzyna Błaszczyk, Chien‐Kuo Lee, Małgorzata Szeląg, K. Sikorski, Branko Braam, Stefan Chmielewski, Tomasz Wrzesiński and Hanna Nowicka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Hans A.R. Bluyssen

71 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans A.R. Bluyssen Poland	33	1.4k	1.2k	927	381	244	72	2.8k
Daniel J. Gough Australia	26	1.2k 0.8×	1.6k 1.4×	1.4k 1.5×	611 1.6×	313 1.3×	46	3.5k
Chilakamarti V. Ramana United States	23	1.5k 1.1×	1.4k 1.2×	1.3k 1.4×	454 1.2×	405 1.7×	42	3.2k
Jun Guo China	31	1.2k 0.9×	1.1k 1.0×	449 0.5×	326 0.9×	338 1.4×	118	3.2k
Eleni Douni Greece	27	1.4k 1.0×	1.2k 1.0×	635 0.7×	465 1.2×	323 1.3×	58	3.2k
Jennifer Major United States	26	1.5k 1.1×	893 0.8×	597 0.6×	428 1.1×	305 1.3×	37	2.9k
Tomoh Matsumiya Japan	30	1.4k 1.0×	1.2k 1.1×	535 0.6×	281 0.7×	381 1.6×	126	3.0k
Gernot Schabbauer Austria	34	1.3k 1.0×	1.5k 1.3×	394 0.4×	402 1.1×	409 1.7×	76	3.5k
Rena Feinman United States	26	1.1k 0.8×	995 0.9×	571 0.6×	361 0.9×	246 1.0×	50	2.6k
Koen Vandenbroeck Spain	30	1.2k 0.9×	856 0.7×	462 0.5×	242 0.6×	286 1.2×	96	2.9k
Hiroaki Takimoto Japan	30	1.7k 1.3×	1.5k 1.3×	436 0.5×	288 0.8×	398 1.6×	85	3.7k

Countries citing papers authored by Hans A.R. Bluyssen

Since Specialization

Citations

This map shows the geographic impact of Hans A.R. Bluyssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans A.R. Bluyssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans A.R. Bluyssen more than expected).

Fields of papers citing papers by Hans A.R. Bluyssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans A.R. Bluyssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans A.R. Bluyssen. The network helps show where Hans A.R. Bluyssen may publish in the future.

Co-authorship network of co-authors of Hans A.R. Bluyssen

This figure shows the co-authorship network connecting the top 25 collaborators of Hans A.R. Bluyssen. A scholar is included among the top collaborators of Hans A.R. Bluyssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans A.R. Bluyssen. Hans A.R. Bluyssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kluzek, Katarzyna, Mahdi Eskandarian Boroujeni, Bart Krist, et al.. (2025). Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis. Frontiers in Pharmacology. 15. 1471182–1471182. 3 indexed citations

Nowicka, Hanna, Katarzyna Błaszczyk, Katarzyna Kluzek, et al.. (2023). ISGF3 and STAT2/IRF9 Control Basal and IFN-Induced Transcription through Genome-Wide Binding of Phosphorylated and Unphosphorylated Complexes to Common ISRE-Containing ISGs. International Journal of Molecular Sciences. 24(24). 17635–17635. 9 indexed citations

Kluzek, Katarzyna, Mahdi Eskandarian Boroujeni, Shota Yamauchi, et al.. (2023). Time-dependent recruitment of GAF, ISGF3 and IRF1 complexes shapes IFNα and IFNγ-activated transcriptional responses and explains mechanistic and functional overlap. Cellular and Molecular Life Sciences. 80(7). 187–187. 15 indexed citations

Wesoły, Joanna, et al.. (2022). SINBAD, structural, experimental and clinical characterization of STAT inhibitors and their potential applications. Scientific Data. 9(1). 139–139. 3 indexed citations

Matuła, Kinga, Łukasz Richter, Marta Janczuk-Richter, et al.. (2019). Phenotypic plasticity of Escherichia coli upon exposure to physical stress induced by ZnO nanorods. Scientific Reports. 9(1). 8575–8575. 26 indexed citations

Krist, Bart, et al.. (2019). Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease. Frontiers in Immunology. 10. 1176–1176. 108 indexed citations

Ziemnicka, Katarzyna, et al.. (2018). Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates. Molecular Cancer. 17(1). 116–116. 53 indexed citations

Błaszczyk, Katarzyna, et al.. (2018). A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses. Frontiers in Immunology. 9. 1135–1135. 222 indexed citations

Szeląg, Małgorzata, Aida Collado, Patrice Marqués, et al.. (2018). Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs. Frontiers in Immunology. 9. 2141–2141. 12 indexed citations

10.

Błaszczyk, Katarzyna, et al.. (2016). The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses. Cytokine & Growth Factor Reviews. 29. 71–81. 109 indexed citations

11.

Wrzesiński, Tomasz, Małgorzata Szeląg, Rachel H. Giles, et al.. (2015). Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors. BMC Cancer. 15(1). 518–518. 83 indexed citations

12.

Szeląg, Małgorzata, Anna Czerwoniec, Joanna Wesoły, & Hans A.R. Bluyssen. (2014). Comparative screening and validation as a novel tool to identify STAT-specific inhibitors. European Journal of Pharmacology. 740. 417–420. 8 indexed citations

13.

Sikorski, K., Stefan Chmielewski, Joanna Wesoły, et al.. (2012). STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction. PubMed. 1(4). 241–249. 52 indexed citations

14.

Sikorski, K., Anna Czerwoniec, Janusz M. Bujnicki, Joanna Wesoły, & Hans A.R. Bluyssen. (2011). STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease. Cytokine & Growth Factor Reviews. 22(4). 211–219. 87 indexed citations

15.

Sikorski, K., Stefan Chmielewski, Łukasz Przybył, et al.. (2011). STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion. American Journal of Physiology-Cell Physiology. 300(6). C1337–C1344. 46 indexed citations

16.

Wesoły, Joanna, K. Sikorski, Chien‐Kuo Lee, & Hans A.R. Bluyssen. (2010). Suppressor of cytokine signaling and accelerated atherosclerosis in kidney disease.. Acta Biochimica Polonica. 57(3). 251–60. 6 indexed citations

17.

Wesoły, Joanna, Zofia Szweykowska-Kulińska, & Hans A.R. Bluyssen. (2007). STAT activation and differential complex formation dictate selectivity of interferon responses.. Acta Biochimica Polonica. 54(1). 27–38. 88 indexed citations

18.

Braam, Branko, Remmert de Roos, Hans A.R. Bluyssen, et al.. (2005). Nitric Oxide–Dependent and Nitric Oxide–Independent Transcriptional Responses to High Shear Stress in Endothelial Cells. Hypertension. 45(4). 672–680. 25 indexed citations

19.

Gaillard, Sandrine, Hilde M. Dijstelbloem, Rob J. Kraaijenhagen, et al.. (2004). Broadly Altered Gene Expression in Blood Leukocytes in Essential Hypertension Is Absent During Treatment. Hypertension. 43(5). 947–951. 52 indexed citations

20.

Lopes, Susana M. Chuva de Sousa, Hans A.R. Bluyssen, Martin van der Valk, et al.. (2003). Receptor protein tyrosine phosphatase mu expression as a marker for endothelial cell heterogeneity; analysis of RPTPmu gene expression using LacZ knock-in mice. The International Journal of Developmental Biology. 47(5). 345–354. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact